Analysis of the significance of echocardiographic signs of right ventricular dysfunction for predicting the outcome of heart failure with reduced left ventricular ejection fraction
Ultrasound & Functional Diagnostics · 2024
DOI: 10.24835/1607-0771-021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ultrasound & Functional Diagnostics, 2024. Verfasst von V. I. Skidan und 5 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Objective: to determine the ultrasound signs of right heart dysfunction, which increase the prognostic value of the recommended parameters of left ventricular (LV) dysfunction in patients with heart failure with reduced ejection fraction (HFrEF). Materials and methods. The prospective study included 79 patients with HFrEF LV with clinical manifestations of chronic heart failure functional class III according to the New York Heart Association (HF NYHA Class III) in 52 patients (65.8%) and HF NYHA Class IV in 27 (34.1%). The primary end point was death during a follow-up period of up to 3 years while waiting for heart transplantation.
Results
Overall mortality was 33 patients (41.7%), 17 (21.5%) during the 1st year of follow-up. Regression analysis revealed the following independent ultrasound predictors of poor prognosis: LV ejection fraction on 3D-echocardiography (3DE LVEF), p = 0.014; global longitudinal strain of the LV (GLS LV), p = 0.010, and of the interventricular septum basal segment (IVSLS BS), p = 0.012; mean longitudinal strain of the basal segment of the right ventricle free wall (FWLS BS RV), p = 0.003. Changes in the configuration and dilatation of the LV cavity, an increase in LV end-diastolic pressure, impaired contractility, and strain of the LV myocardium can affect the function of the right ventricle (RV) through the common interventricular septum (IVS). Dilatation of the RV due to an increase in the end diastolic area (RV EDA) of more than 30 cm2 (p = 0.012) and end systolic area (RV ESA) of more than 25 cm2 (p = 0.001), an increase in the volume of the right atrium (3DE AKI) of more than 100 ml (p = 0.036), and a decrease in the % inspiratory collapse of the inferior vena cava (% IVC) less than 30% (p = 0.005) demonstrated a prognostic significance in the observed patients. A decrease in the deformation properties of the pancreas due to the longitudinal component and impaired strain of the basal segment makes a greater contribution to RV dysfunction (FWLS BS, % < -15% (p < 0.001)).
Conclusions
RV dysfunction in patients with HFrEF is an unfavorable prognostic factor, independently associated with existing LV dysfunction. The most significant ultrasound sign for surveillance prediction of patients with LV HFrEF and RV dysfunction are indicators of ventricular myocardial deformation. Remodeling of the right chambers and dysfunction of the RV is a trigger for the separation of the RV and pulmonary artery, which ultimately leads to adverse outcomes.
Zitieren
APA
Skidan, V. I., Pavlyukova, E. N., Nartsissova, G. P., Voronkov, V. M., Astapov, D. A., & Rosseykin, E. V. (2024). Analysis of the significance of echocardiographic signs of right ventricular dysfunction for predicting the outcome of heart failure with reduced left ventricular ejection fraction. Ultrasound & Functional Diagnostics. https://doi.org/10.24835/1607-0771-021
Vancouver
Skidan VI, Pavlyukova EN, Nartsissova GP, Voronkov VM, Astapov DA, Rosseykin EV. Analysis of the significance of echocardiographic signs of right ventricular dysfunction for predicting the outcome of heart failure with reduced left ventricular ejection fraction. Ultrasound & Functional Diagnostics. 2024. doi:10.24835/1607-0771-021
BibTeX
@article{Skidan2024,
author = {Skidan, V. I. and Pavlyukova, E. N. and Nartsissova, G. P. and Voronkov, V. M. and Astapov, D. A. and Rosseykin, E. V.},
title = {Analysis of the significance of echocardiographic signs of right ventricular dysfunction for predicting the outcome of heart failure with reduced left ventricular ejection fraction},
journal = {Ultrasound & Functional Diagnostics},
year = {2024},
doi = {10.24835/1607-0771-021}
}
EUVIMED